GB0521275D0 - 3-Aminoindole compounds - Google Patents

3-Aminoindole compounds

Info

Publication number
GB0521275D0
GB0521275D0 GBGB0521275.8A GB0521275A GB0521275D0 GB 0521275 D0 GB0521275 D0 GB 0521275D0 GB 0521275 A GB0521275 A GB 0521275A GB 0521275 D0 GB0521275 D0 GB 0521275D0
Authority
GB
United Kingdom
Prior art keywords
aminoindole
compounds
aminoindole compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0521275.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GBGB0521275.8A priority Critical patent/GB0521275D0/en
Publication of GB0521275D0 publication Critical patent/GB0521275D0/en
Priority to PCT/GB2006/003872 priority patent/WO2007045867A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
GBGB0521275.8A 2005-10-19 2005-10-19 3-Aminoindole compounds Ceased GB0521275D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0521275.8A GB0521275D0 (en) 2005-10-19 2005-10-19 3-Aminoindole compounds
PCT/GB2006/003872 WO2007045867A1 (en) 2005-10-19 2006-10-18 3 -aminoindole compounds as crth2 receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0521275.8A GB0521275D0 (en) 2005-10-19 2005-10-19 3-Aminoindole compounds

Publications (1)

Publication Number Publication Date
GB0521275D0 true GB0521275D0 (en) 2005-11-30

Family

ID=35458291

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0521275.8A Ceased GB0521275D0 (en) 2005-10-19 2005-10-19 3-Aminoindole compounds

Country Status (2)

Country Link
GB (1) GB0521275D0 (en)
WO (1) WO2007045867A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2658986C (en) 2006-08-07 2014-11-25 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
BRPI0820872A2 (en) 2007-12-14 2015-07-21 Pulmagen Therapeutics Asthma Ltd Indoles and their therapeutic.
EP2321267A2 (en) * 2008-08-15 2011-05-18 F. Hoffmann-La Roche AG Monoaryl aminotetralines
CA2735392A1 (en) * 2008-08-15 2010-02-18 F. Hoffmann-La Roche Ag Bi-aryl aminotetralines
PT2558447E (en) 2010-03-22 2014-11-25 Actelion Pharmaceuticals Ltd 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
MY165623A (en) 2011-04-14 2018-04-18 Idorsia Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
US20140328861A1 (en) 2011-12-16 2014-11-06 Atopix Therapeutics Limited Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
UA117780C2 (en) 2014-03-17 2018-09-25 Ідорсія Фармасьютікалз Лтд Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
RU2016140708A (en) 2014-03-18 2018-04-18 Идорсиа Фармасьютиклз Лтд Acetic acid derivatives of azaindole and their use as modulators of the prostaglandin receptor D2
CN105461693B (en) * 2014-09-26 2019-10-25 广东东阳光药业有限公司 CRTH2 agonist compounds and application thereof
WO2017046125A1 (en) 2015-09-15 2017-03-23 Actelion Pharmaceuticals Ltd Crystalline forms
US20230339886A1 (en) * 2020-06-23 2023-10-26 University Of Florida Research Foundation, Incorporated Rev-erb agonists for the treatment of th17-mediated inflammatory disorders
WO2023122093A1 (en) * 2021-12-20 2023-06-29 University Of Florida Research Foundation, Incorporated Rev-erb agonists for th17-mediated inflammatory disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097598A1 (en) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Compound exhibiting pgd 2 receptor antagonism
SE0201635D0 (en) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0302232D0 (en) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds

Also Published As

Publication number Publication date
WO2007045867A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
GB0508472D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0508463D0 (en) Compounds
GB0521275D0 (en) 3-Aminoindole compounds
GB0502299D0 (en) Compounds
GB0502310D0 (en) Compounds
AP2007004220A0 (en) Motilide compounds
GB0505084D0 (en) Compounds
GB0503961D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0506467D0 (en) Compounds
GB0505086D0 (en) Compounds
GB0508460D0 (en) Compounds
GB0505509D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0501985D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0501857D0 (en) Compounds
GB0500891D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)